Projects per year
- 1 - 50 out of 831 results
Search results
-
EU
-
-
PrecisionTox: New Approach Methodologies for Chemical Safety
Viant, M., Lee, R., Roberts, R., Orsini, L., Müller, F., Zhou, J., Colbourne, J., Weber, R. & Cavoski, A.
1/02/21 → 31/01/26
Project: EU
-
The role of the G protein-coupled receptor, LGR4, in bone metabolism and obesity
1/09/19 → 31/08/24
Project: EU
-
-
PRedictors for Stability of Treatment Outcomes - Molecular Markers (PRESTO-M)
1/09/22 → 31/08/25
Project: EU
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
-
Industry
-
Sequential Study - Funding of Clinical Trial Co-ordinator for NEAT Study.
Rea, D.
1/08/00 → 31/12/25
Project: Industry
-
-
ATALANTa Study - A-alpha val 360 contract
Stockley, R. & Scott, A.
1/06/23 → 31/05/27
Project: Industry
-
Pilot and study for RIISC cohort
Sharma, P., Chapple, I., Grant, M. & Kebschull, M.
1/03/23 → 28/02/26
Project: Industry
-
Best practice for implementation of PROs in real world evidence generation
1/10/20 → 30/09/24
Project: Industry
-
MSD MISP Grant: Restoring immunoregulation in early PSC and IBD.
17/10/22 → 16/10/25
Project: Industry
-
Immunotherapeutic Targeting of Pancreatic Cancer
Contino, G., Croft, W., Moss, P., Middleton, G. & Pearce, H.
9/09/21 → 8/09/24
Project: Industry
-
Global Study of Novel Agents in relapsed and refractory B-NHL with ADCT
Billingham, L., Kearns, P., Siddique, S. & Holt, G.
1/08/21 → 31/01/28
Project: Industry
-
FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
Jackson, A., Fox, S. & Craddock, C.
3/12/21 → 30/06/26
Project: Industry
-
-
AZ Case studentship - Macrophages And The Microbiome In Respiratory Disease
1/10/21 → 30/09/25
Project: Industry
-
-
-
NOSTRA-Feasibility study: A prospective non-randomised multi-centre feasibility study to assess if patients with residual cancer following dual-targeted neoadjuvant chemotherapy treatment for HER2-positive, ER-negative early breast cancer..
Pirrie, S., Rea, D., Gaunt, C. & Billingham, L.
1/01/18 → 31/12/25
Project: Industry
-
Post-doctoral Fellowship Program on Patient-direct Drug Development
Cruz Rivera, S., Aiyegbusi, L. & Calvert, M.
1/12/22 → 30/11/25
Project: Industry
-
Glo-BNHL: Regeneron Collaboration - A Global Study Of Novel Agents In Relapsed And Refractory B-Non Hodgkin Lymphoma (B-NHL)
Kearns, P., Billingham, L., Maycock, S., Holt, G. & Siddique, S.
1/07/23 → 30/06/28
Project: Industry
-
Evaluation of the prognostic and predictive significance of fusion genes in epithelial ovarian cancer
1/09/22 → 31/12/24
Project: Industry
-
COSI: An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high risk myelodysplasia undergoing allogeneic stem cell transplantation
Craddock, C. & Jackson, A.
Jazz Pharmaceuticals, ADIENNE s.r.l
1/09/19 → 31/12/26
Project: Industry
-
AMADEUS - Double-blind,IMPACT phase III,Randomised Study to Compare the Efficacy and Safety to Oral AZA(CC-486)Versus Placebo in Subject with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoieti
Craddock, C., Siddique, S. & Jackson, A.
1/04/18 → 31/03/28
Project: Industry
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. & Middleton, G.
21/10/15 → 31/12/24
Project: Industry
-
Investigation and development of immunodiagnostic tests for the human antibody response to viruses
1/03/21 → 28/02/26
Project: Industry